Bayerische Motoren Werke AG vs Johnson & Johnson: Strategic Comparison
Key Differences at a Glance
| Field | Bayerische Motoren Werke AG | Johnson & Johnson |
|---|---|---|
| Revenue | $144.1B | $94.2B |
| Founded | 1916 | 1886 |
| Employees | 154,540 | 140,800 |
| Market Cap | $50.0B | $612.8B |
| Headquarters | Germany | United States |
Quick Stats Comparison
| Metric | Bayerische Motoren Werke AG | Johnson & Johnson |
|---|---|---|
| Revenue | $144.1B | $94.2B |
| Founded | 1916 | 1886 |
| Headquarters | Munich, Germany | New Brunswick, New Jersey |
| Market Cap | $50.0B | $612.8B |
| Employees | 154,540 | 140,800 |
Bayerische Motoren Werke AG Revenue vs Johnson & Johnson Revenue — Year by Year
| Year | Bayerische Motoren Werke AG | Johnson & Johnson | Leader |
|---|---|---|---|
| 2025 | $144.1B | $94.2B | Bayerische Motoren Werke AG |
| 2024 | $153.8B | $88.8B | Bayerische Motoren Werke AG |
| 2023 | $167.9B | $85.2B | Bayerische Motoren Werke AG |
| 2022 | $154.0B | N/A | Bayerische Motoren Werke AG |
| 2021 | $120.1B | N/A | Bayerische Motoren Werke AG |
Business Model Breakdown
Overview: Bayerische Motoren Werke AG vs Johnson & Johnson
This in-depth comparison examines Bayerische Motoren Werke AG and Johnson & Johnson across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Bayerische Motoren Werke AG on its own, evaluating Johnson & Johnson, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Bayerische Motoren Werke AG and Johnson & Johnson is widest.
On the headline numbers, Bayerische Motoren Werke AG reports annual revenue of $144.1B against $94.2B for Johnson & Johnson, while their respective market capitalizations stand at $50.0B and $612.8B. Bayerische Motoren Werke AG is headquartered in Germany and Johnson & Johnson operates from United States, and those different home markets shape how each company competes.
Bayerische Motoren Werke AG: BMW's history runs from aircraft engines to motorcycles to premium automobiles. Its modern identity is built on engineering, design, driving dynamics, and a disciplined premium portfolio.
Johnson & Johnson: Johnson & Johnson began as a medical-products company in the nineteenth century and became a diversified healthcare giant. After the Kenvue separation, it is a more focused healthcare company centered on medicine and medical technology.
Business Models: How Bayerische Motoren Werke AG and Johnson & Johnson Make Money
Bayerische Motoren Werke AG and Johnson & Johnson pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Bayerische Motoren Werke AG and Johnson & Johnson.
Bayerische Motoren Werke AG business model: BMW earns revenue from premium vehicle sales, motorcycles, parts and accessories, leasing, financing, insurance, and aftersales services. Its Financial Services segment helps convert vehicle demand into recurring finance and leasing relationships.
Johnson & Johnson business model: Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.
Competitive Advantage: Bayerische Motoren Werke AG vs Johnson & Johnson
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Bayerische Motoren Werke AG stack up against those of Johnson & Johnson.
Bayerische Motoren Werke AG competitive advantage: BMW's advantage is premium pricing power, engineering credibility, brand loyalty, financial-services integration, and a flexible approach across EV, hybrid, combustion, and hydrogen technologies.
Johnson & Johnson competitive advantage: Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.
Growth Strategy: Where Bayerische Motoren Werke AG and Johnson & Johnson Are Headed
Future prospects matter as much as current results. The growth strategies below explain how Bayerische Motoren Werke AG and Johnson & Johnson each plan to expand from here.
Bayerische Motoren Werke AG growth strategy: BMW's growth strategy is to refresh the product portfolio with Neue Klasse technologies, expand electrified sales, keep a flexible drivetrain strategy, and use financial services to deepen customer retention.
Johnson & Johnson growth strategy: The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.
Financial Picture: Bayerische Motoren Werke AG vs Johnson & Johnson
A closer look at the financial trajectory of Bayerische Motoren Werke AG and Johnson & Johnson rounds out the comparison.
Bayerische Motoren Werke AG: For FY2025, BMW reported EUR133.453B in group revenue, EUR10.236B in profit before tax, and EUR7.451B in net profit. This profile stores those native EUR figures and keeps the site-standard revenue display at about $144.1B.
Johnson & Johnson: Johnson & Johnson's FY2025 sales increased 6.0% to $94.193 billion. Net earnings rose to $26.804 billion, helped by operating performance and other income items. Innovative Medicine generated $60.401 billion in sales, while MedTech generated $33.792 billion.
Company-Specific SWOT Notes
Bayerische Motoren Werke AG
BMW's brand, driving dynamics, and global production system support pricing power.
EVs, batteries, software, and new platforms require heavy investment while margins are under pressure.
The Neue Klasse platform and Gen6 battery technology can refresh BMW's product cycle.
Competitive pricing in China, tariffs, and regulatory demands can compress automotive margins.
Johnson & Johnson
Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.
Johnson & Johnson wins through medical trust, R&D scale, global reach, leading drug franchises, MedTech breadth, and commercial execution.
The biggest risk is patent, pricing, litigation, or R&D pressure that weakens growth in key pharmaceutical and MedTech franchises.
The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | Bayerische Motoren Werke AG | Bayerische Motoren Werke AG reports the larger revenue base ($144.1B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | Johnson & Johnson | Founded in 1916 vs 1886. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Bayerische Motoren Werke AG | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | Bayerische Motoren Werke AG | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | Johnson & Johnson | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
Bayerische Motoren Werke AG reports the larger revenue base ($144.1B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1916 vs 1886. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: Bayerische Motoren Werke AG or Johnson & Johnson?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: Bayerische Motoren Werke AG vs Johnson & Johnson
Is Bayerische Motoren Werke AG better than Johnson & Johnson?
Verdict: Between Bayerische Motoren Werke AG and Johnson & Johnson, Bayerische Motoren Werke AG is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, Bayerische Motoren Werke AG comes out ahead in this Bayerische Motoren Werke AG vs Johnson & Johnson comparison.
Who earns more — Bayerische Motoren Werke AG or Johnson & Johnson?
Bayerische Motoren Werke AG earns more with $144.1B in annual revenue versus Johnson & Johnson's $94.2B. Bayerische Motoren Werke AG leads on total revenue based on latest verified figures.
Which company has higher revenue — Bayerische Motoren Werke AG or Johnson & Johnson?
Bayerische Motoren Werke AG reported $144.1B, while Johnson & Johnson reported $94.2B. The revenue leader is Bayerische Motoren Werke AG based on latest verified figures.
Bayerische Motoren Werke AG revenue vs Johnson & Johnson revenue — which is higher?
Bayerische Motoren Werke AG revenue: $144.1B. Johnson & Johnson revenue: $94.2B. Bayerische Motoren Werke AG has the larger revenue base of the two companies.
Sources & References
- Bayerische Motoren Werke AG Corporate Website
- Bayerische Motoren Werke AG Annual Report 2025 - Revenue and Financial Data
- bmwgroup.com
- bmwgroup.com
- bmwgroup.com
- bmwgroup.com
- SEC EDGAR: Johnson & Johnson Annual Filings (10-K, 8-K)
- Johnson & Johnson Corporate Website
- Johnson & Johnson Annual Report 2025 - Revenue and Financial Data
- sec.gov